Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 55-64

  Samuel, Derina S ^a   Ewton, D Z ^a   Coolican, S A ^a   Petley, T D ^a   McWade, F J ^b   Florini, J R ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

LY294002; MAP kinase; P70 S6 kinase; PD098059; PI 3 kinase; Signal transduction; Skeletal muscle; Raf 1:ER

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CREATINE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MYOGENIN; RAF PROTEIN; RAS PROTEIN; S6 KINASE; SOMATOMEDIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALIA;

EID: 0032922703     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978699     Document Type: Article

References (59)

1. 1. Ewton DZ, Florini JR. Effect of somatomedins and insulin on myoblast differentiation in vitro. Develop Biol 1981; 86: 31 -9
2. 2. Konigsberg IR. Diffusion-mediated control of myoblast fusion. Develop Biol 1971; 26: 133-52
3. 3. Allen RE, Boxhorn LK. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor-I, and fibroblast growth factor. J Cell Physiol 1989; 138: 311 -5
4. 4. Schmid Ch, Steiner Th, Froesch ER. Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF-I and IGF-II) in primary cultures of chicken embryonic cells. FEBS Letters 1983; 161: 117-21
5. 5. Pinset C, Montarras D, Chenevert J, Minty A, Barton P, Lauerent C, Gros F. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation 1988; 38: 28-34
6. 6. Rosenthal SM, Cheng Z-Q. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci 1995; 92: 10307-11
7. 7. Engert JC, Berglund EB, Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 1996; 135: 431-40
8. 8. Damon SE, Haugk KL, Birnbaum RS, Quinn LS. Retrovirally mediated overexpression of insulin-like growth factor binding protein 4: evidence that insulin-like growth factor is required for skeletal muscle differentiation. J Cell Physiol 1998; 175: 109-24
9. 9. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR. IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 1994; 161: 277-84
10. 10. Andres V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon moygenesis. J Cell Biol 1996; 132: 657-66
11. 11. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 1997; 272: 12699-7 02
12. 12. Daum G, Eisenmann-Tappe I, Fries HW, Troppmair J, Rapp UR. The ins and outs of Raf kinases. Trends Biochem Sci 1994; 19: 474-80
13. 13. Avruch J, Zhang XF, Kryiakis JM. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 1994; 19: 279-83
14. 14. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996; 8: 205-15
15. 15. Leevers SJ, Paterson HF, Marshall CJ. Requirement for ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 1994; 369: 411 -4
16. 16. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science 1994; 264: 1463 -7
17. 17. Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 1995; 14: 3136-45
18. 18. Jelinek T, Dent P, Sturgill TW, Weber MJ. Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol 1996; 16: 1027-34
19. 19. Wartmann M, Hofer P, Turowski P, Saltiel AR, Haynes NE. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J Biol Chem 1997; 272: 3915-23
20. 20. Alessi D, Cuenda A, Cohen P, Dudley D, Saltiel A. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-94
21. 21. Dudley D, Pang L, Decker S, Bridges A, Saltiel A. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995; 92: 7686 -9
22. 22. Lenormand P, McMahon M, Pouyssegur J. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J Biol Chem 1996; 271: 15762 -8
23. 23. Sewing A, Wiseman B, Lloyd AC, Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 1997; 17: 5588-97
24. 24. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf-1 activity with arrest mediated by p21Cip1. Mol Cell Biol 1997; 17: 5598-6 11
25. 25. Porras A, Muszynski K, Rapp RR, Santos E. Dissociation between activation of Raf-1 kinase and the 42-kDa mitogen-activated protein kinase/90-kDa S6 kinase cascade in the insulin/Ras pathway of adipocyte differentiation in 3T3-L. J Biol Chem 1994; 269: 12741 -8
26. 26. Samuels ML, Weber MJ, Bishop JM, McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol Cell Biol 1993; 13: 6241-52
27. 27. Florini JR. Assay of creatine kinase in microtiter plates using thio-NAD to allow monitoring at 405 nm. Anal Biochem 1989; 182: 399-4 04
28. 28. Laemmli UK. Cleavage of structural proteins during assembly of the head. Nature 1970; 227: 680 -5
29. 29. Bosch E, Cherwinski H, Peterson D, McMahon M. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1. Oncogene 1997; 15: 1021-33
30. 30. Pritchard CA, Michael SL, Bosch E, McMahon M. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol Cell Biol 1995; 15: 6430-42
31. 31. Ewton DZ, Florini JR. Insulin-like growth factor binding proteins -4, -5, and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J Endocrinol 1995; 144; 539-53
32. 32. Florini JR, Ewton DZ, Roof SL. IGF-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Molecular Endocrinol 1991a; 5: 718-24
33. 33. Kaliman P, Canico J, Shepherd PR, Beeton CA, Testar X, Palacin M, Zorzano A. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 1997; 12: 66-77
34. 34. Liu J-L, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factors I (IGF-I) and type 1 IGF receptor (IGF1r). Cell 1993; 75: 59-72
35. 35. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA. IGF-I is required for normal embryonic growth in mice. Genes & Develop 1993; 7: 2609-17
36. 36. Hasty P, Bradley A, Morris JH, Edmondson DC, Venuti JM, Olson EN, Klein WH. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993; 364: 501-35
37. 37. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I, Nabeshima Y. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993; 364: 532 -5
38. 38. Kaliman P, Vinals F, Textar X, Palacin M, Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 1996; 271: 19146-51
39. 39. Pinset C, Garcia A, Rousse S, Dubois C, Montarras D. Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2. Compt Rendu Acad Sci Paris 1997; 320: 367-74
40. 40. Kolch W, Heidecker G, Lloyd P, Rapp UR. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 1991; 349: 426 -8
41. 41. Schaap D, van der Wal J, Howe LR, Marshall CJ, van Blitterswijk WJ. A dominant negative mutant of Raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21 ras. J Biol Chem 1993; 268: 20232 -6
42. 42. Samuels ML, McMahon M. Inhibition of PDGF and EGF-mediated mitogenesis and signaling in 3T3 cells expressing DRaf-1:ER, an estradiol-regulated form of Raf-1. Mol Cell Biol 1994; 14: 7855-66
43. 43. Lassar AB, Thayer MJ, Overell RW, Weintraub H. Transformation by activated RAS or FOS prevents myogenesis by inhibiting expression of MyoD1. Cell 1989; 58: 659-67
44. 44. Olson EN, Spizz G, Tainsky MA. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 1987; 7: 2104-11
45. 45. Gossett LA, Zhang W, Olson EN. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes. J Cell Biol 1988; 106: 2127-38
46. 46. Sternberg EA, Spizz G, Perry ME, Olson EN. A ras-dependent pathway abolishes activity of a muscle-specific enhancer upstream from the muscle creatine kinase gene. Mol Cell Biol 1989; 9: 594-6 01
47. 47. Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the myoD1 gene. Oncogene 1989; 4: 473-81
48. 48. Florini J, Magri K, Ewton D, James P, Grindstaff K, Rotwein P. "Spontaneous" differentiation of skeletal myoblasts is controlled by autocrine secretion of insulin-like growth factor-II. J Biol Chem 1991; 266: 15917-23
49. 49. Rodriguez-Viciana P, Marte BM, Warne PH, Downward J. Phosphatidylinositol 3′ kinase: one of the effectors of Ras. Phil Trans R Soc Lond B 1996; 351: 225-32
50. 50. Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene 1997; 14: 697-7 04
51. 51. Ramocki MB, Johnson SE, White MA, Ashendel CL, Konieczny SF, Taparowsky EJ. Signaling throught mitogen-activated protein kinase and rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis. Mol Cell Biol 1997; 17: 3547-55
52. 52. De Mora JF, Porras A, Ahn N, Santos E. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol 1997; 17: 6068-75
53. 53. Bennett AM, Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997; 278: 1288-91
54. 54. Sarbassov DD, Jones LB, Peterson CA. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol Endocrinol 1997; 11: 2038-20 47
55. 55. Ming XF, Burgering BM, Wennstrom S, Claesson-Welsh L, Heldin CH, Bos JL, Kozma SC, Thomas G. Activation of p70/p85 S6 kinase by pathway independent of p21 Ras. Nature 1994; 371: 426 -9
56. 56. Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, Rapp UR. Mitogen-activated protein kinase/Extracellular signal-regulated protein kinase activation by oncogenes, serum and TPA requires Raf and is necessary for transformation. J Biol Chem 1994; 269: 7030 -5
57. 57. Williams NG, Paradis H, Agarwal S, Charest DL, Pelech SL, Roberts TM. Raf-1 and p21v-Ras cooperate in the activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 1993; 90: 5772 -6
58. 58. Marshall M. Interactions between Ras and Raf: Key regulatory proteins in cellular transformation. Mol Reproduct Devel 1995; 42: 493 -9
59. 59. Petley T, Graff K, Jiang W, Yang H, Florini J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm Metab Res 1999; 31: 70 -6